Stay updated on Cabozantinib for PN in NF1: Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.
Latest updates to the Cabozantinib for PN in NF1: Clinical Trial page
- Check5 days agoChange DetectedLocations section added listing all sites by state and state-specific location headers removed, consolidating site information in one place. Revision updated to v3.3.3.SummaryDifference1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPubMed-related notes in the Publications and Deletions sections were updated, adding Revision: v3.3.2 for additions and Revision: v3.2.0 for deletions.SummaryDifference0.1%
- Check41 days agoChange DetectedA notice about a lapse in government funding and potential delays was removed from the page; core trial details such as eligibility, endpoints, and locations remain unchanged.SummaryDifference0.3%
- Check55 days agoChange DetectedThe changes are limited to formatting and wording updates on the Study Details page, with no changes to study design, endpoints, eligibility criteria, or enrollment figures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check84 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%
- Check91 days agoChange DetectedThe page now shows Revision: v3.1.0 replacing Revision: v3.0.2. This is a version update to the core page metadata.SummaryDifference0.0%
Stay in the know with updates to Cabozantinib for PN in NF1: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for PN in NF1: Clinical Trial page.